These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1643857)

  • 1. On the assessment of bioequivalence in a two-period cross-over design.
    Wijnand HP
    Comput Methods Programs Biomed; 1992 Mar; 37(2):151-7. PubMed ID: 1643857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence revisited: non-parametric analysis of two-period cross-over studies.
    Wijnand HP
    Comput Methods Programs Biomed; 1993 Aug; 40(4):249-59. PubMed ID: 8261772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of bioequivalence in a two-period cross-over design: development of a simple BASIC program.
    Meineke I; de Mey C
    Comput Methods Programs Biomed; 1991 Jun; 35(2):151-3. PubMed ID: 1914453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample sizes for bioequivalence studies.
    Metzler CM
    Stat Med; 1991 Jun; 10(6):961-9; discussion 969-70. PubMed ID: 1876786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple BASIC program for the calculation of nonparametric confidence intervals in bioequivalence testing.
    Meineke I
    Comput Methods Programs Biomed; 1987 Feb; 24(1):65-71. PubMed ID: 3829651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance intervals for assessing individual bioequivalence.
    Brown EB; Iyer HK; Wang CM
    Stat Med; 1997 Apr; 16(7):803-20. PubMed ID: 9131767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On population and individual bioequivalence.
    Schall R; Luus HG
    Stat Med; 1993 Jun; 12(12):1109-24. PubMed ID: 8210816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence studies: biometrical concepts of alternative designs and pooled analysis.
    Zintzaras E; Bouka P
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):225-32. PubMed ID: 10716060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalence.
    Hauck WW; Hauschke D; Diletti E; Bois FY; Steinijans VW; Anderson S
    J Biopharm Stat; 1997 Mar; 7(1):179-89. PubMed ID: 9056597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the evaluation of individual bioequivalence.
    Endrenyi L
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms for evaluating reference scaled average bioequivalence: power, bias, and consumer risk.
    Tothfalusi L; Endrenyi L
    Stat Med; 2017 Nov; 36(27):4378-4390. PubMed ID: 28850696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical methods for the evaluation of individual bioequivalence criteria.
    Kimanani EK; Lavigne J; Potvin D
    Stat Med; 2000 Oct; 19(20):2775-95. PubMed ID: 11033575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach for the assessment of bioequivalence under selected higher-order cross-over designs.
    Vuorinen J
    Stat Med; 1997 Oct; 16(19):2229-43. PubMed ID: 9330430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the statistical analysis of bioequivalence studies.
    Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.
    Tempelman RJ
    J Anim Sci; 2004; 82 E-Suppl():E162-172. PubMed ID: 15471796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
    Schall R
    Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carry-over effects in bioequivalence studies.
    Dangelo G; Potvin D; Turgeon J
    J Biopharm Stat; 2001; 11(1-2):35-43. PubMed ID: 11459441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.